简介:Syros Pharmaceuticals, Inc.于2011年11月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,致力于为血液系统恶性肿瘤患者的一线治疗制定新的护理标准。该公司正在推进一项后期临床计划,其中包括候选主要产品:(i)Tamibarotene,一种选择性视黄酸受体α激动剂,该公司正在进行SELECT-MDS-1,这是一项3期临床试...
Get real-time Syros Pharma (SYRS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.
SYRS Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -97.56% Syros Pharmaceuticals, Inc. price and volume Combination chart with 2 data series. Chart represents Syros Pharmaceuticals, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The ...
Stock Information for Syros Pharmaceuticals Inc. 1D 5D 1M 3M 6M 1Y 2Y 3Y 5Y 10Y 20Y Volume: PriceVolumeFrequency:DAILYMar 18Mar 19Mar 20Mar 21Mar 22Mar 25Mar 26Mar 27Mar 28Mar 29Apr 1Apr 2Apr 3Apr 4Apr 5Apr 8Apr 9Apr 10Apr 11Apr 12Apr 15Apr 16Apr 17Apr 180.0250.050.0750.10.12...
Syros Pharmaceuticals, Inc. today announced that its Board of Directors has approved and the Company intends to proceed with the voluntary delisting of its common stock from the Nasdaq Stock Market and the deregistration of its common stock in order to t